Prevalence, trends, and distribution of hepatitis C virus among the general population in sub‐Saharan Africa: A systematic review and meta‐analysis
Liver International · 2024-12 · 44 (12) · 3238-3249
DOI: 10.1111/liv.16102 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Liver International, online erschienen am 13.09.2024. Verfasst von Getahun Molla Kassa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health and Care Research.
Abstract (Originalsprache)
Background and Aims Although the evidence is uncertain, existing estimates for hepatitis C virus (HCV) in sub‐Saharan Africa (SSA) indicate a high burden. We estimated HCV seroprevalence and viraemic prevalence among the general population in SSA.
Methods
We searched Medline, Embase, Web of Science, APA PsycINFO, and World Health Organization Africa Index Medicus for community‐based studies. Study quality was assessed using the Joanna Briggs Institute critical appraisal tool, and heterogeneity using the index of heterogeneity ( I 2 ). Two approaches were deployed. First, we used random‐effects meta‐analysis to pool prevalence. Second, to derive representative estimates, we weighted each country's HCV seroprevalence using 2021 United Nations country population sizes.
Results
We synthesized 130 studies. Overall, SSA HCV seroprevalence from the random‐effects model was 4.17% (95% confidence interval [CI]: 3.71–4.66, I 2 = 99.30%). There were no differences between males (4.31%) and females (4.03%). Seroprevalence was 2.25%, 3.31%, and 16.23% for ages ≤20, 21–64, and ≥65 years, respectively, and was higher in rural (6.63%) versus urban (2.93%). There was indication of decrement overtime from 5.74% to 4.35% to 3.03% in the years 1984–2000, 2001–2014, and 2015–2023, respectively. The weighted overall SSA HCV seroprevalence was estimated to be 2.30% (95% CI: 1.59–3.00) with regional variation: Africa‐Southern (.79%), Africa‐Central (1.47%), Africa‐Eastern (2.71%), and Africa‐Western (2.88%). HCV viremia among HCV seropositives was 54.77% (95% CI: 47.80–61.66).
Conclusions
HCV seroprevalence in SSA remains high. Populations aged ≥65 years, rural communities, Africa‐Western, and some countries in Africa‐Central and Africa‐Eastern appear disproportionately affected. These results underline the need for governmental commitment to achieve the 2030 global HCV elimination targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
ORCID-Profile: Getahun Molla Kassa, Josephine G Walker, Tesfa Sewunet Alamneh, John F Dillon, Peter Vickerman, Matthew Hickman, Clare E French, Aaron G Lim
Förderung
- Wellcome Trust
- National Institute for Health and Care Research
Zitieren
APA
Kassa, G. M., Walker, J. G., Alamneh, T. S., Tamiru, M. T., Bivegete, S., Adane, A., Amogne, W., Dillon, J. F., Vickerman, P., Dagne, E., Yesuf, E. A., Hickman, M., French, C. E., Lim, A. G., & DESTINE NIHR Global Health Research Group (2024). Prevalence, trends, and distribution of hepatitis C virus among the general population in sub‐Saharan Africa: A systematic review and meta‐analysis. Liver International, 44(12), 3238-3249. https://doi.org/10.1111/liv.16102
Vancouver
Kassa GM, Walker JG, Alamneh TS, Tamiru MT, Bivegete S, Adane A, et al. Prevalence, trends, and distribution of hepatitis C virus among the general population in sub‐Saharan Africa: A systematic review and meta‐analysis. Liver International. 2024;44(12):3238-3249. doi:10.1111/liv.16102
BibTeX
@article{Kassa2024,
author = {Kassa, Getahun Molla and Walker, Josephine G and Alamneh, Tesfa Sewunet and Tamiru, Melaku Tileku and Bivegete, Sandra and Adane, Aynishet and Amogne, Wondwossen and Dillon, John F and Vickerman, Peter and Dagne, Emebet and Yesuf, Elias Ali and Hickman, Matthew and French, Clare E and Lim, Aaron G and DESTINE NIHR Global Health Research Group, DESTINE NIHR Global Health Research Group},
title = {Prevalence, trends, and distribution of hepatitis C virus among the general population in sub‐Saharan Africa: A systematic review and meta‐analysis},
journal = {Liver International},
year = {2024},
volume = {44},
number = {12},
pages = {3238--3249},
doi = {10.1111/liv.16102}
}
EUVIMED